NORMAN RIENDEAU: Open Payments
NPI 1275585432 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 27 payments from 8 companies in 2025. Trend: 2023 $1,778 · 2024 $1,725 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $453 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $186 |
| Lilly USA, LLC | 3 | $157 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $25 |
| PFIZER INC. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Ozempic, MOUNJARO, JARDIANCE, CAPVAXIVE, Wegovy, GEMTESA, Cologuard Collection Kit, ELIQUIS.
Industry payments across VA — which companies pay providers there.
